Free Review Articles on Sepsis                                 Metatextbook

Freie Reviews über Sepsis                                 Look here for Journal Homepages




  • Sepsis
  • ADH
  • Corticosteroids
  • Infusion therapy
  • Endothelial dysfunction
  • SIRS (Systemic inflammatory response syndrome)
  • Neutrophil extracellular traps
  • Interleukin27
  • Blood vessles (Vascular access)
  • Staphylococcus aureus
  • NK cells
  • Protein C
  • Blood vessels (Permeability)
  • Glycocalyx
  • Heparan sulfate
  • Syndecan
  • Apoptosis
  • Procalcitonin
  • Antiinflammatory compounds
  • PAR1
  • Drotrecogin alpha
  • Antioxidants
  • Glucocorticoids
  • Statics and trial design
  • Erythropoietin
  • Artificial ventilation (BASKET)
  • Receptor (RAGE)
  • Neutropenia (Fever neutropenic)
  • Kupffer cell
  • C5a
  • Regulatory T cell
  • Statin
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    12010Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).



    +-nlGer Med Sci 8(-):Doc14 (2010)
    22003Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nurses.



    +-nlAm J Crit Care 12(2):120-33; quiz 134-5 (2003)
    32008Surviving sepsis: a guide to the guidelines.



    +-nlCrit Care 12(3):162 (2008)
    42007Diagnosis and treatment of severe sepsis.



    +-nlCrit Care 11 Suppl 5(-):S2 (2007)
    52006Rescue therapy in septic shock--is terlipressin the last frontier?



    +-nlCrit Care 10(2):131 (2006) Leone M
    62005Clinical review: Vasopressin and terlipressin in septic shock patients.



    +-nlCrit Care 9(2):212-22 (2005) Delmas A
    72004Bench-to-bedside review: sepsis is a disease of the microcirculation.



    +-nlCrit Care 8(6):462-8 (2004) Spronk PE
    82004Clinical review: corticotherapy in sepsis.



    +-nlCrit Care 8(2):122-9 (2004)
    92003Bench-to-bedside review: microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide.



    +-nlCrit Care 7(5):359-73 (2003)
    102002Clinical review: Hypertonic saline resuscitation in sepsis.



    +-nlCrit Care 6(5):418-23 (2002)
    112002The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock.



    +-nlCrit Care 6(5):384-6 (2002)
    122002The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock.



    +-nlCrit Care 6(5):381-3 (2002)
    132003Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?



    +-nlCrit Care 7(2):130-8 (2003)
    142003Science review: role of coagulation protease cascades in sepsis.



    +-nlCrit Care 7(2):123-9 (2003) Riewald M
    152002Clinical review: Myocardial depression in sepsis and septic shock.



    +-nlCrit Care 6(6):500-8 (2002)
    162006Critical care in the emergency department: severe sepsis and septic shock.



    +-nlEmerg Med J 23(9):713-7 (2006)
    172006The pathogenesis and molecular biology of sepsis.



    +-nlCrit Care Resusc 8(3):227-9 (2006)
    182005Recent insights into the pathogenesis of severe sepsis.



    +-nlCrit Care Resusc 7(1):32-9 (2005)
    192004Metabolic acidosis in patients with sepsis: epiphenomenon or part of the pathophysiology?



    +-nlCrit Care Resusc 6(3):197-203 (2004)
    202003Catecholamines in the treatment of septic shock: effects beyond perfusion.



    +-nlCrit Care Resusc 5(4):270-6 (2003)
    212006Role of KATP channels in sepsis.



    +-nlCardiovasc Res 72(2):220-30 (2006)
    221998The haematological manifestations of sepsis.



    +-nlJ Antimicrob Chemother 41 Suppl A(-):17-24 (1998)
    231998Cardiovascular alterations in septic shock.



    +-nlJ Antimicrob Chemother 41 Suppl A(-):9-15 (1998)
    242003Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.



    +-nlClin Microbiol Rev 16(3):379-414 (2003)
    251993Gram-negative sepsis: a dilemma of modern medicine.



    +-nlClin Microbiol Rev 6(1):57-68 (1993)
    261990Quantitative aspects of septicemia.



    +-nlClin Microbiol Rev 3(3):269-79 (1990)
    272009Statins for sepsis: a critical and updated review.



    +-nlClin Microbiol Infect 15(4):325-34 (2009)
    282009Activated protein C for the treatment of severe sepsis.



    +-nlClin Microbiol Infect 15(4):319-24 (2009)
    292009The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis.



    +-nlClin Microbiol Infect 15(4):308-18 (2009)
    302009Non-antibiotic strategies for sepsis.



    +-nlClin Microbiol Infect 15(4):302-7 (2009)
    312008Sepsis: rethinking the approach to clinical research.



    +-nlJ Leukoc Biol 83(3):471-82 (2008)
    322008Inflammation, endothelium, and coagulation in sepsis.



    +-nlJ Leukoc Biol 83(3):536-45 (2008)
    332008Sepsis: a clinical update.



    +-nlClin J Am Soc Nephrol 3(2):571-7 (2008)
    342008Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis.



    +-nlJ Thromb Haemost 6(3):415-20 (2008)
    352002The cardiovascular response in sepsis: proposed mechanisms of the beneficial effect of adrenomedullin and its binding protein (review).



    +-nlInt J Mol Med 9(5):443-9 (2002)
    362000Mechanism of hepatocellular dysfunction during sepsis: the role of gut-derived norepinephrine (review).



    +-nlInt J Mol Med 5(5):457-65 (2000)
    372005Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.



    +-nlCMAJ 173(9):1054-65 (2005)
    382008Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.



    +-nlAcad Emerg Med 15(5):399-413 (2008)
    392007New therapies for sepsis: focus on the interleukin (IL)12 family member IL27.



    +-nlAnn Rheum Dis 66 Suppl 3(-):iii29-31 (2007)
    402007Physiological monitoring for critically ill patients: testing a predictive model for the early detection of sepsis.



    +-nlAm J Crit Care 16(2):122-30; quiz 131 (2007)
    412007Sepsis: definition, epidemiology, and diagnosis.



    +-nlBMJ 335(7625):879-83 (2007)
    422007Management of sepsis.



    +-nlBMJ 335(7626):929-32 (2007)
    432011Managing bloodstream infections in patients who have short-term central venous catheters.



    +-nlCleve Clin J Med 78(1):10-7 (2011)
    442010The host response to sepsis and developmental impact.



    +-nlPediatrics 125(5):1031-41 (2010)
    452010Mechanisms and regulation of the gene-expression response to sepsis.



    +-nlPediatrics 125(6):1248-58 (2010)
    462007Managing the nervous system effects of sepsis.



    +-nlChest 131(5):1273-4 (2007)
    472008Fluid therapy in resuscitated sepsis: less is more.



    +-nlChest 133(1):252-63 (2008)
    482009Staphylococcus aureus bloodstream infections: definitions and treatment.



    +-nlClin Infect Dis 48 Suppl 4(-):S254-9 (2009)
    492009Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.



    +-nlClin Infect Dis 48 Suppl 4(-):S260-70 (2009)
    502009Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis.



    +-nlClin Infect Dis 49(1):93-101 (2009)
    512011The role of natural killer cells in sepsis.



    +-nlJ Biomed Biotechnol 2011(-):986491 (2011)
    522005Effects of recombinant human activated protein C in human models of endotoxin administration.



    +-nlProc Am Thorac Soc 2(3):243-7 (2005)
    532010Sepsis-induced degradation of endothelial glycocalix.



    +-nlScientificWorldJournal 10(-):917-23 (2010)
    542010Insights into sepsis therapeutic design based on the apoptotic death pathway.



    +-nlJ Pharmacol Sci 114(4):354-65 (2010)
    552006Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy.



    +-nlJ Pharmacol Sci 101(3):189-98 (2006)
    562010Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.



    +-nlBr J Pharmacol 159(2):253-64 (2010)
    572009Protective mechanisms of activated protein C in severe inflammatory disorders.



    +-nlBr J Pharmacol 158(4):1034-47 (2009)
    582003The enigma of sepsis.



    +-nlJ Clin Invest 112(4):460-7 (2003)
    592004Toward resolving the challenges of sepsis diagnosis.



    +-nlClin Chem 50(8):1301-14 (2004)
    602009Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study.



    +-nlAm J Respir Crit Care Med 180(9):861-6 (2009)
    612011Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.



    +-nlCrit Care 15(1):R58 (2011)
    622010Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis.



    +-nlCrit Care 14(4):230 (2010)
    632010Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.



    +-nlCrit Care 14(4):R134 (2010)
    642010Corticosteroids for sepsis: registry versus Cochrane systematic review!



    +-nlCrit Care 14(4):185 (2010)
    652010Bench to bedside: A role for erythropoietin in sepsis.



    +-nlCrit Care 14(4):227 (2010)
    662010Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry.



    +-nlCrit Care 14(3):R102 (2010)
    672010Cerebral perfusion in sepsis.



    +-nlCrit Care 14(2):215 (2010)
    682010Sepsis biomarkers: a review.



    +-nlCrit Care 14(1):R15 (2010)
    692009Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?



    +-nlCrit Care 13(3):214 (2009)
    702009Bench-to-bedside review: ventilatory abnormalities in sepsis.



    +-nlCrit Care 13(1):202 (2009)
    712008Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.



    +-nlCrit Care 12(1):201 (2008)
    722008Cellular processes in sepsis.



    +-nlSwiss Med Wkly 138(43-44):629-34 (2008)
    732007Management of severe sepsis of abdominal origin.



    +-nlScand J Surg 96(3):184-96 (2007)
    742009Revisiting steroid treatment for septic shock: molecular actions and clinical effects--a review.



    +-nlMem Inst Oswaldo Cruz 104(4):531-48 (2009)
    752010Molecular microbiological methods in the diagnosis of neonatal sepsis.



    +-nlExpert Rev Anti Infect Ther 8(9):1037-48 (2010)
    762011Biomarkers for pediatric sepsis and septic shock.



    +-nlExpert Rev Anti Infect Ther 9(1):71-9 (2011)
    772009Treatment of septic shock and use of drotrecogin alfa (activated) in children.



    +-nlExpert Rev Anti Infect Ther 7(7):769-72 (2009)
    782007Pharmacologic support of infants and children in septic shock.



    +-nlJ Pediatr (Rio J) 83(2 Suppl):S36-45 (2007)
    792007New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients.



    +-nlJ Pediatr (Rio J) 83(2 Suppl):S54-63 (2007)
    802007What tests can help diagnose and estimate the severity of sepsis?



    +-nlJ Pediatr (Rio J) 83(4):297-8 (2007) Lacroix J
    812007Adrenal function in sepsis and septic shock.



    +-nlJ Pediatr (Rio J) 83(5 Suppl):S155-62 (2007)
    822010Recent insights into the pathogenesis of bacterial sepsis.



    +-nlNeth J Med 68(4):147-52 (2010)
    832002Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections.



    +-nlJ Leukoc Biol 72(2):239-48 (2002)
    842004The chronic consequences of severe sepsis.



    +-nlJ Leukoc Biol 75(3):408-12 (2004)
    852004The roles of insulin and hyperglycemia in sepsis pathogenesis.



    +-nlJ Leukoc Biol 75(3):413-21 (2004)
    862003A key role of C5a/C5aR activation for the development of sepsis.



    +-nlJ Leukoc Biol 74(6):966-70 (2003)
    872009Editorial: Mouse models to study sepsis syndrome in humans.



    +-nlJ Leukoc Biol 86(2):199-201 (2009) Warren HS
    882008Regulatory T cell populations in sepsis and trauma.



    +-nlJ Leukoc Biol 83(3):523-35 (2008)
    892004The heart and circulation in severe sepsis.



    +-nlBr J Anaesth 93(1):114-20 (2004)
    902008Statins and sepsis.



    +-nlBr J Anaesth 100(3):288-98 (2008)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.